Pfizer Stock News

Let's take a look at some healthcare ETFs that are regaining popularity among investors as COVID-19 cases rise in China.

Pfizer is expected to seek authorization for a fourth dose in its COVID-19 vaccine regimen for seniors, The Associated Press reported Tuesday. The additional booster shot would go to Americans ages 65 and up, in an effort to provide additional protection to age groups that are more vulnerable to serious illness by the coronavirus. The request to the Food and Drug Administration and the Centers for Disease Control has not yet been submitted, but Pfizer''s CEO Albert Bourla said earlier this week he believes a fourth dose is necessary. "The protection that you are getting from the third [dose], it is good enough, actually quite good for hospitalizations and deaths," he told CBS'' Face the Nation . "It''s not that good against infections, but doesn''t last very long. But we are just submitting those data to the FDA and then we will see what the experts also will say outside Pfizer." Pfizer has rolled out COVID-19 vaccines and boosters with varying regimens for specific age groups. Most recently, it postponed its request for approval for a shot for kids under age 5, saying it wants to compare data between a two-dose and three-dose regimen.

Here''s your TL;DR for this morning''s news.

Pfizer and BioNTech could seek emergency use authorization from the US Food and Drug Administration for a second booster shot of their Covid-19 vaccine for people 65 and older as soon as Tuesday, in news first reported by The Washington Post.

Pfizer will ask the Food and Drug Administration (FDA) to authorize a second COVID-19 vaccine booster dose for adults over the age of 65, two people familiar with the situation told The New York Times.The sources said the company could request the…

Drugmaker Pfizer is expected to request authorization this week for an additional COVID-19 booster dose for seniors

The move could reignite a tortuous debate that raged last year among scientists over how often people need to bolster the vaccines’ protection.

AP Source: Pfizer expected to request authorization this week for additional COVID-19 vaccine booster dose for seniors

Pfizer CEO Albert Bourla previously said that a fourth coronavirus vaccine is "necessary" to protect against COVID-19.

Pfizer Inc and its German partner BioNTech SE will seek emergency use authorization for a second booster shot of their COVID-19 vaccine for people aged 65 and older, the Washington Post reported on Tuesday.

Pfizer (PFE) and BioNTech (BNTX) will seek to expand authorization of their COVID-19 vaccine to include a second booster shot for adults 65 years and older.

Resurgent worries about COVID-19 appear to be behind the stock's gains.

Pfizer''s CEO thinks a fourth booster is necessary, while Moderna''s president thinks an additional booster shot is only needed for some people.